# AEON Biopharma, Inc.: filings

AEON · NYSE · CIK 1837607 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aeon.md) · [Financials](/companies/aeon/financials.md) · [Filings](/companies/aeon/filings.md) · [Insiders](/companies/aeon/insiders.md)

## Reports and events: 145 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 86, 4 51, 3 20, 10-Q 17, UPLOAD 17, CORRESP 16, DEFA14A 15, 425 14, SCHEDULE 13G 8, S-1/A 7, SCHEDULE 13G/A 7, 10-K 6, DEF 14A 6, EFFECT 6, 10-K/A 5, 10-Q/A 5, 424B3 5, PRE 14A 5, SC 13G 5, 424B5 4, S-4/A 4, 8-K/A 3, ARS 3, S-1 3, S-8 3, SC 13G/A 3, 424B4 2, 4/A 2, 8-A12B 2, CERT 2, DRS 2, NT 10-Q 2, S-1MEF 2, S-3 2, SC 13D 2, SCHEDULE 13D 2, SCHEDULE 13D/A 2, 144 1, 25 1, 25-NSE 1, ARS/A 1, DEFM14A 1, DEFR14A 1, DEL AM 1, S-4 1, S-4MEF 1, SC 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 16:15 ET | [8-K](/filings/0001837607-26-000071.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001837607-26-000071 |
| 2026-09-30 | 08:00 ET | [8-K](/filings/0001837607-26-000064.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001837607-26-000064 |
| 2026-08-12 | 16:17 ET | [10-Q](/filings/0001837607-26-000062.md) | Quarterly report, period 2026-06-30 | 0001837607-26-000062 |
| 2026-08-12 | 16:15 ET | [8-K](/filings/0001837607-26-000061.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001837607-26-000061 |
| 2026-08-03 | 16:15 ET | [8-K](/filings/0001837607-26-000057.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001837607-26-000057 |
| 2026-07-23 | 16:01 ET | [8-K](/filings/0001837607-26-000055.md) | 8.01 Other events | 0001837607-26-000055 |
| 2026-07-15 | 16:01 ET | [8-K](/filings/0001837607-26-000052.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001837607-26-000052 |
| 2026-07-09 | 10:57 ET | [S-1/A](/filings/0001104659-26-082167.md) | Registration statement, amended | 0001104659-26-082167 |
| 2026-07-08 | 17:26 ET | [S-1](/filings/0001104659-26-081860.md) | Registration statement | 0001104659-26-081860 |
| 2026-06-17 | 16:05 ET | [8-K](/filings/0001837607-26-000046.md) | 5.07 Shareholder vote results | 0001837607-26-000046 |
| 2026-05-14 | 16:10 ET | [8-K](/filings/0001837607-26-000043.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001837607-26-000043 |
| 2026-05-14 | 16:07 ET | [10-Q](/filings/0001837607-26-000042.md) | Quarterly report, period 2026-03-31 | 0001837607-26-000042 |
| 2026-05-14 | 16:06 ET | [8-K](/filings/0001837607-26-000041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001837607-26-000041 |
| 2026-04-29 | 17:18 ET | [DEF 14A](/filings/0001837607-26-000033.md) | Proxy statement, period 2026-04-29 | 0001837607-26-000033 |
| 2026-04-03 | 16:05 ET | [8-K](/filings/0001837607-26-000025.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001837607-26-000025 |
| 2026-03-30 | 17:36 ET | [10-K](/filings/0001837607-26-000019.md) | Annual report, period 2025-12-31 | 0001837607-26-000019 |
| 2026-03-30 | 17:29 ET | [8-K](/filings/0001837607-26-000018.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001837607-26-000018 |
| 2026-03-09 | 16:05 ET | [8-K](/filings/0001837607-26-000009.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001837607-26-000009 |
| 2026-01-29 | 21:24 ET | [SCHEDULE 13D](/filings/0001213900-26-009802.md) | Ownership report, active investor | 0001213900-26-009802 |
| 2026-01-29 | 21:03 ET | [SCHEDULE 13D/A](/filings/0001213900-26-009785.md) | Ownership report, active investor, amended | 0001213900-26-009785 |
| 2026-01-21 | 16:06 ET | [8-K](/filings/0001837607-26-000005.md) | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001837607-26-000005 |
| 2026-01-12 | 09:17 ET | [8-K](/filings/0001837607-26-000002.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001837607-26-000002 |
| 2025-12-29 | 16:05 ET | [DEF 14A](/filings/0001837607-25-000104.md) | Proxy statement, period 2025-12-29 | 0001837607-25-000104 |
| 2025-12-15 | 16:11 ET | [8-K](/filings/0001837607-25-000092.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001837607-25-000092 |
| 2025-12-04 | 09:02 ET | [8-K](/filings/0001837607-25-000088.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001837607-25-000088 |
| 2025-11-14 | 08:35 ET | [10-Q](/filings/0001837607-25-000085.md) | Quarterly report, period 2025-09-30 | 0001837607-25-000085 |
| 2025-11-14 | 08:31 ET | [8-K](/filings/0001837607-25-000084.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001837607-25-000084 |
| 2025-11-13 | 08:30 ET | [8-K](/filings/0001837607-25-000072.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001837607-25-000072 |
| 2025-09-08 | 17:00 ET | [8-K](/filings/0001837607-25-000068.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001837607-25-000068 |
| 2025-08-12 | 16:07 ET | [10-Q](/filings/0001837607-25-000066.md) | Quarterly report, period 2025-06-30 | 0001837607-25-000066 |
| 2025-08-12 | 16:06 ET | [8-K](/filings/0001837607-25-000065.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001837607-25-000065 |
| 2025-06-13 | 16:05 ET | [8-K](/filings/0001837607-25-000059.md) | 5.07 Shareholder vote results | 0001837607-25-000059 |
| 2025-06-11 | 16:06 ET | [10-Q/A](/filings/0001104659-25-058535.md) | Quarterly report, amended, period 2025-03-31 | 0001104659-25-058535 |
| 2025-06-11 | 16:05 ET | [10-K/A](/filings/0001104659-25-058531.md) | Annual report, amended, period 2024-12-31 | 0001104659-25-058531 |
| 2025-05-20 | 16:04 ET | [8-K](/filings/0001837607-25-000055.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001837607-25-000055 |
| 2025-05-14 | 16:10 ET | [10-Q](/filings/0001837607-25-000050.md) | Quarterly report, period 2025-03-31 | 0001837607-25-000050 |
| 2025-05-14 | 16:09 ET | [8-K](/filings/0001837607-25-000049.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001837607-25-000049 |
| 2025-04-29 | 16:06 ET | [DEF 14A](/filings/0001837607-25-000035.md) | Proxy statement, period 2024-12-31 | 0001837607-25-000035 |
| 2025-04-25 | 16:06 ET | [8-K](/filings/0001837607-25-000032.md) | 3.01 Delisting notice | 0001837607-25-000032 |
| 2025-04-21 | 16:11 ET | [8-K](/filings/0001837607-25-000030.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001837607-25-000030 |
| 2025-04-08 | 16:02 ET | [8-K](/filings/0001837607-25-000027.md) | 5.02 Departure or appointment of officers or directors | 0001837607-25-000027 |
| 2025-03-27 | 16:06 ET | [8-K](/filings/0001837607-25-000025.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001837607-25-000025 |
| 2025-03-24 | 16:07 ET | [10-K](/filings/0001837607-25-000022.md) | Annual report, period 2024-12-31 | 0001837607-25-000022 |
| 2025-03-24 | 16:06 ET | [8-K](/filings/0001837607-25-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001837607-25-000021 |
| 2025-03-10 | 06:00 ET | [8-K](/filings/0001837607-25-000015.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001837607-25-000015 |
| 2025-03-07 | 16:01 ET | [SCHEDULE 13D/A](/filings/0001104659-25-021722.md) | Ownership report, active investor, amended | 0001104659-25-021722 |
| 2025-02-24 | 14:01 ET | [8-K](/filings/0001837607-25-000013.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001837607-25-000013 |
| 2025-02-07 | 16:07 ET | [8-K](/filings/0001837607-25-000010.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001837607-25-000010 |
| 2025-01-23 | 16:45 ET | [DEF 14A](/filings/0001837607-25-000007.md) | Proxy statement, period 2025-02-24 | 0001837607-25-000007 |
| 2025-01-22 | 16:02 ET | [SCHEDULE 13D](/filings/0001104659-25-005235.md) | Ownership report, active investor | 0001104659-25-005235 |

Page 1 of 3. [Older](/companies/aeon/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:43 ET. No prices; not investment advice.